The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery
Open accessAbstract
Ocular diseases can deteriorate vision to the point of blindness and thus can have a major impact on the daily life of an individual. Conventional therapies are unable to provide absolute therapy for all ocular diseases due to the several limitations during drug delivery across the blood-retinal barrier, making it a major clinical challenge. With recent developments, the vast number of publications undergird the need for nanotechnology-based drug delivery systems in treating ocular diseases. The tool of nanotechnology provides several essential advantages, including sustained drug release and specific tissue targeting. Additionally, comprehensive in vitro and in vivo studies have suggested a better uptake of nanoparticles across ocular barriers. Nanoparticles can overcome the blood-retinal barrier and consequently increase ocular penetration and improve the bioavailability of the drug. In this review, we aim to summarize the development of organic and inorganic nanoparticles for ophthalmic applications. We highlight the potential nanoformulations in clinical trials as well as the products that have become a commercial reality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoemulsions: Formation, properties and applications
Gupta, A., Eral, H. B., Hatton, T. A., & Doyle, P. S. (2016) · Soft Matter · doi:10.1039/c5sm02958a · Cited by 1,633
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Polymer-Based Nanomaterials for Drug-Delivery Carriers
Yadav, H. K. S., Almokdad, A. A., shaluf, S. I. M., & Debe, M. S. (2019) · Nanocarriers for Drug Delivery · doi:10.1016/b978-0-12-814033-8.00017-5 · Cited by 148 · cited 2×
“Polymeric nanoparticles are spherical-shaped solid colloidal particles composed of biocompatible and biodegradable polymers in a size range from 10 nm to 1000 nm [32].”
BackgroundEffects of Gold Nanoparticles on Endotoxin-Induced Uveitis in Rats
Pereira, D. V., Petronilho, F., Pereira, H. R. S. B., Vuolo, F., Mina, F., Possato, J. C., Vitto, M. F., de Souza, D. R., da Silva, L., da Silva Paula, M. M., et al. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10743 · Cited by 76
Cited by
Preparation and application of pH-responsive drug delivery systems
Ding, H., Tan, P., Fu, S., Tian, X., Zhang, H., Ma, X., Gu, Z., & Luo, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.056 · Cited by 645
Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases
Onugwu, A. L., Nwagwu, C. S., Onugwu, O. S., Echezona, A. C., Agbo, C. P., Ihim, S. A., Emeh, P., Nnamani, P. O., Attama, A. A., & Khutoryanskiy, V. V. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.018 · Cited by 350
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 277
Ocular drug delivery: advancements and innovations
Tian, B., Bilsbury, E., Doherty, S., Teebagy, S., Wood, E., Su, W., Gao, G., & Lin, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091931 · Cited by 50
Metadata
- Authors
- Khiev, D., Mohamed, Z. A., Vichare, R., Paulson, R., Bhatia, S., Mohapatra, S., Lobo, G. P., Valapala, M., Kerur, N., Passaglia, C. L., Mohapatra, S. S., & Biswal, M. R.
- Venue
- Nanomaterials
- Publisher
- MDPI AG
- Published
- 2021-01-12
- Volume
- 11
- Issue
- 1
- Pages
- 173
- ISSN
- 2079-4991 (ISSN-L)
- OpenAlex
- W3119705211
- Cited by
- 180
- References
- 4
- FWCI
- 10.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery. https://app.cochat.ai/papers/10.3390/nano11010173
- The paper
- Khiev, D., Mohamed, Z. A., Vichare, R., Paulson, R., Bhatia, S., Mohapatra, S., Lobo, G. P., Valapala, M., Kerur, N., Passaglia, C. L., Mohapatra, S. S., & Biswal, M. R. (2021). Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery. Nanomaterials. https://doi.org/10.3390/nano11010173
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.